Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Lifestance Health (LFST)

LifeStance Q1 revenue rises 11% to $333.0 million; net income $0.7 million

Positive Impact 3 of 5 earnings Written later

LifeStance Health Group reported first-quarter 2025 revenue of $333.0 million, up 11% from $300.4 million a year earlier, and net income of $0.7 million compared with a net loss of $21.1 million in the prior-year quarter. The company reaffirmed its full-year 2025 guidance for revenue, Center Margin and Adjusted EBITDA, and gave second-quarter revenue guidance of $332 million to $352 million.

Key points

  • Q1 2025 revenue of $333.0 million, up 11%; Adjusted EBITDA of $34.6 million, up 25%
  • Net income of $0.7 million versus a net loss of $21.1 million in Q1 2024
  • Net cash used in operations was $3.1 million in Q1; cash ended the quarter at $134.3 million
  • Full-year 2025 guidance reiterated: revenue $1.40 billion to $1.44 billion; Adjusted EBITDA $130 million to $150 million

The filing

CompanyLifestance Health (LFST)
Form8-K, current report
Filed with the SECMay 6, 2025, 6:33 PM ET
Accession number0000950170-25-064745

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.